Skip to main content
Sisram Medical Ltd logo

Sisram Medical Ltd — Investor Relations & Filings

Ticker · 1696 ISIN · IL0011418113 HKEX Manufacturing
Filings indexed 1,569 across all filing types
Latest filing 2021-09-24 Interim / Quarterly Rep…
Country HK Hong Kong
Listing HKEX 1696

About Sisram Medical Ltd

http://www.sisram-medical.com

Sisram Medical Ltd. is a global consumer wellness group specializing in medical aesthetics and minimally invasive solutions. Leveraging over two decades of expertise, the company is a leader in Energy-Based Devices (EBD), harnessing natural energy sources for both aesthetic and medical clinical indications. Sisram operates through a synergistic ecosystem of brands, providing medical-grade quality solutions to professional customers and consumers worldwide. Key segments include Alma, a provider of energy-based solutions for surgical and medical aesthetics markets; LMNT, a personal care brand for home use; Copulla, which offers end-to-end digital dentistry services; and a dedicated injectables portfolio. The company's extensive product range covers treatments such as hair removal, skin rejuvenation, body contouring, and dermal fillers.

Recent filings

Filing Released Lang Actions
INTERIM REPORT 2021
Interim / Quarterly Report Classification · 100% confidence The document contains detailed financial statements such as Interim Condensed Consolidated Statement of Profit or Loss, Statement of Comprehensive Income, Statement of Financial Position, Statement of Changes in Equity, and Statement of Cash Flows. It also includes Management Discussion and Analysis, Chairman's and CEO's statements, and notes to the interim condensed consolidated financial statements. The document covers the six months ended June 30, 2021, indicating it is a comprehensive financial report for a period shorter than a full fiscal year. The length of the document (15,000 characters) and the presence of substantive financial data confirm it is an Interim / Quarterly Report rather than a brief announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR). H1 2021
2021-09-24 English
PROPOSED ADOPTION OF THE 2021 RSU SCHEME PROPOSED GRANTING OF THE RSU SCHEME ANNUAL MANDATE PROPOSED ADOPTION OF THE REMUNERATION POLICY FOR DIRECTORS AND OFFICERS AND CONNECTED TRANSACTIONS RELATING
Board/Management Information Classification · 95% confidence The document is an announcement from Sisram Medical Ltd regarding the proposed adoption of a 2021 Restricted Share Unit (RSU) Scheme, the proposed granting of the RSU Scheme annual mandate, the proposed adoption of a remuneration policy for directors and officers, and connected transactions relating to RSU grants to connected participants. It discusses board approvals, shareholder approvals to be sought at an Extraordinary General Meeting (EGM), details of the RSU scheme, and connected transactions involving directors and senior staff. The document is an announcement of proposed governance and remuneration-related matters, including connected transactions and mandates, rather than a full remuneration report or proxy statement. It is not a full remuneration report (DEF 14A), nor a proxy solicitation (PSI), but rather an announcement of proposed board and shareholder actions related to remuneration and share schemes. The document is not a full annual report, earnings release, or financial report. It is a regulatory announcement about board and shareholder proposals on remuneration and share schemes, including connected transactions disclosures. Therefore, the best fitting category is Board/Management Information (MANG), as it relates to board proposals and management-related remuneration policies and share scheme adoption announcements.
2021-09-09 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2021
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return regarding movements in securities, specifically focusing on authorized and issued share capital, share options, convertibles, and confirmations related to securities issued by Reliance Global Holdings Limited. It includes detailed tables of share capital changes, types of shares, and confirmations by an executive director. The document is addressed to the Hong Kong Exchanges and Clearing Limited and references compliance with listing rules. It is not a full annual or interim financial report, nor is it an earnings release or management discussion. It is a regulatory submission related to share capital movements and confirmations, which fits the category of a Regulatory Filing (RNS) as it does not fit other more specific categories and is a compliance document rather than a financial report or announcement of a report.
2021-09-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2021
Share Issue/Capital Change Classification · 95% confidence The document is a monthly return report for movements in securities, specifically detailing the movements in authorized and issued shares of Sisram Medical Ltd for the month ended 31 August 2021. It includes information on share capital, issued shares, and confirms no changes in share options, warrants, convertibles, or other agreements. The document is submitted to the Hong Kong Exchanges and Clearing Limited and follows a regulatory reporting format under Chapter 19B of the Exchange Listing Rules. It is not a full financial report, earnings release, or management discussion, but rather a regulatory filing reporting share capital and share movements. The document length is 4438 characters, which is relatively short and focused on share capital movements. This fits the definition of a Share Issue/Capital Change (SHA) filing, which covers announcements regarding new share issues, stock splits, or other capital changes. Therefore, the appropriate classification is SHA with high confidence.
2021-09-02 English
SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE ANNUAL REPORT OF THE COMPANY FOR THE YEAR ENDED 31 MARCH 2021
Regulatory Filings Classification · 95% confidence The document is titled as a 'Supplemental Announcement in Relation to the Annual Report of the Company for the Year Ended 31 March 2021'. It references the Annual Report published earlier and provides additional information specifically about pension schemes. The document length is only 2520 characters, which is quite short and it is an announcement supplementing the Annual Report rather than the full report itself. It does not contain full financial statements or comprehensive financial data but rather additional disclosures related to the Annual Report. According to the 'Menu vs Meal' rule, short documents that provide additional or supplemental information to a report are announcements rather than the report itself. Therefore, this document should be classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous announcements that do not fit other specific categories.
2021-08-30 English
PROXY FORM FOR USE AT THE ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a proxy form for use at the annual general meeting (AGM) of Reliance Global Holdings Limited. It includes instructions for shareholders to appoint proxies to vote on resolutions at the AGM, including adoption of audited financial statements, re-election of directors, appointment of auditors, and granting mandates to directors. The content is procedural and related to voting at the AGM rather than the actual AGM materials or reports. It is not a presentation or detailed report but a form for shareholders to exercise their voting rights. Therefore, this document fits the category of Proxy Solicitation & Information Statement (PSI). The document length (6973 characters) and content confirm it is not a brief announcement or a full report but a proxy form for the AGM.
2021-08-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.